Laboratoires Pierre Fabre Streamlines Operations with Mistral-Powered Document Processing
Laboratoires Pierre FabreMistralLaboratoires Pierre Fabre built a tailored solution on Mistral's models to enhance data processing, analysis, and synthesis, as well as translation and document production, improving efficiency in file treatment, analysis and synthesis tasks, document production prompts, and answering open-ended questions across the dermo-cosmetics and pharmaceutical company's operations.
Overview
Laboratoires Pierre Fabre built a tailored solution on Mistral's models to enhance data processing, analysis, and synthesis, as well as translation and document production, improving efficiency in file treatment, analysis and synthesis tasks, document production prompts, and answering open-ended questions across the dermo-cosmetics and pharmaceutical company's operations.
This entry has 10 published fields tied to exact passages in an immutable source capture.
Inspect the highlighted sourceThe challenge
Laboratoires Pierre Fabre needed to optimize and streamline its daily operations and tasks, including data processing, analysis and synthesis, translation, and document production, across its dermo-cosmetics and pharmaceutical business.
The solution
Pierre Fabre built a tailored solution powered by Mistral's models to enhance data processing, analysis, and synthesis, as well as translation and document production, covering tasks such as file treatment and analysis, diverse prompts for document production, and answering open-ended questions.
Reported business value
By integrating Mistral, Pierre Fabre significantly enhanced its operational capabilities, enabling more efficient and effective processes across the organization and positioning the company at the forefront of innovation in the dermo-cosmetics and pharmaceutical industries.
Sources
Open any source and check the claim yourself — that is the point of the register.
This record was researched and written with AI assistance, and its claims were checked against the sources above. (EU AI Act art. 50 transparency notice.)
Other pharmaceuticals entries in the register.
Novo Nordisk Scales to 2,500+ Use Cases with Secure Generative AI Using Amazon Bedrock
Novo Nordisk built a self-service generative AI platform on AWS, using Amazon Bedrock's foundation models, so employees could build and customize chatbots for nonregulated business use cases without needing to develop applications or maintain infrastructure themselves. The company worked with AWS Partner Cloud2 Oy (previously KeyCore) to validate the architecture for security and scalability. More than 25,000 Novo Nordisk employees have used the platform to create chatbots for over 2,500 unique use cases, such as retrieving information, drafting documents, or acting as a virtual colleague or critic. The company's general-purpose chatbot is used by more than 1,000 employees and processes over 26,000 prompts a month; its largest use case was trained on 140,000 documents. Each use case costs around $10 per month to run on AWS, using serverless services including Amazon DynamoDB and AWS Lambda. Building a chatbot now takes days rather than months, and some tasks that took a full day can be completed in as little as 10 minutes.
Novo Nordisk· DenmarkAmazon Bedrock · AWS Lambda · Amazon DynamoDBNovo Nordisk accelerates clinical insight with custom agents on Azure
Novo Nordisk wanted to accelerate pharmaceutical R&D decision-making by helping researchers explore and validate clinical hypotheses faster using AI-assisted quantitative analysis. Working with Microsoft's AI Acceleration Studio (Forward Deployed Engineering team), Novo Nordisk built a governed reasoning agent on Azure, drawing on its FounData initiative which harmonized more than 200,000 patient-years of clinical trial data aligned to CDISC, SDTM, and ADaM industry standards. The agent lets researchers ask complex scientific questions in natural language and generate and execute code against proprietary clinical datasets, with human-in-the-loop validation by biostatisticians before outputs influence decisions. Before production rollout, the teams ran thousands of automated tests and layered evaluation systems. The solution is reducing time to insight from weeks to minutes and increasing the number of scientific questions teams can evaluate from roughly 5-10 strong ideas per quarter to 50+.
Novo Nordisk A/S· DenmarkMicrosoft Azure · Microsoft AI Acceleration Studio
Roche launches NVIDIA AI factory to accelerate the development of new therapeutics and diagnostics solutions
Roche deployed 2,176 NVIDIA Blackwell GPUs on premises across the United States and Europe, bringing its combined on-premise and cloud GPU infrastructure to more than 3,500 Blackwell GPUs. The AI factory is embedded across the value chain: NVIDIA BioNeMo powers Roche's Lab-in-the-Loop strategy connecting biological and chemistry experiments with AI models in R&D; NVIDIA Omniverse-powered digital twins optimize manufacturing production lines and factory designs; accelerated computing and NVIDIA Parabricks analyze diagnostics datasets and digital pathology images; and NVIDIA NeMo Guardrails support healthcare-grade conversational AI in digital health. The expansion builds on a NVIDIA collaboration that started in 2023, and Roche's U.S. subsidiary Genentech also leverages the infrastructure for drug discovery.
Roche· SwitzerlandNVIDIA Blackwell · NVIDIA BioNeMo · NVIDIA Omniverse +2
Novo Nordisk Scales to 2,500+ Generative AI Use Cases with Amazon Bedrock
Danish pharmaceutical company Novo Nordisk built a self-service generative AI platform on Amazon Bedrock that lets employees build and customize chatbots for nonregulated business processes. More than 25,000 employees have used the platform to create chatbots for over 2,500 use cases, cutting the time to build a chatbot from months to days, at an average cost of about $10 per use case per month.
Was this helpful?
Your feedback helps us improve our use case database